Basit öğe kaydını göster

Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes

dc.contributor.authorYuksel, Murat
dc.contributor.authorAdemoglu, Evin
dc.contributor.authorKaya, Aysem
dc.contributor.authorCan, Gunay
dc.contributor.authorYuksel, Husniye
dc.contributor.authorOnat, Altan
dc.date.accessioned2021-03-04T15:04:44Z
dc.date.available2021-03-04T15:04:44Z
dc.date.issued2017
dc.identifier.citationKaya A., Onat A., Yuksel H., Can G., Yuksel M., Ademoglu E., "Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes", POSTGRADUATE MEDICINE, cilt.129, sa.6, ss.611-618, 2017
dc.identifier.issn0032-5481
dc.identifier.othervv_1032021
dc.identifier.otherav_84d78287-3b03-4de8-802d-371dd52847cc
dc.identifier.urihttp://hdl.handle.net/20.500.12627/90352
dc.identifier.urihttps://doi.org/10.1080/00325481.2017.1342508
dc.description.abstractObjectives: Some evidence suggests that serum lipoprotein[Lp](a) may be inversely linked to type-2 diabetes. We aimed to determine in nondiabetic people the relationship of serum [Lp](a) with insulin resistance and new-onset diabetes (NOD).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTıp
dc.subjectTemel Tıp Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.titleLipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes
dc.typeMakale
dc.relation.journalPOSTGRADUATE MEDICINE
dc.contributor.departmentDicle Üniversitesi , ,
dc.identifier.volume129
dc.identifier.issue6
dc.identifier.startpage611
dc.identifier.endpage618
dc.contributor.firstauthorID91147


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster